Literature DB >> 7045217

Serotypes of Escherichia coli isolated from patients with recurrent pyogenic cholangitis.

W T Wong, K A Bettelheim, F C Cheng, G B Ong.   

Abstract

Strains of Escherichia coli were isolated from laparotomy specimens from Chinese patients with recurrent pyogenic cholangitis in Hong Kong. A large variety of serotypes were found. Several sites were sampled in each patient. While only one serotype was normally isolated from one site, different sites often yielded different serotypes in the same patient. Generally the 'O' types found did not correspond to those found in the faeces of the Hong Kong Chinese population.

Entities:  

Mesh:

Year:  1982        PMID: 7045217      PMCID: PMC2134100          DOI: 10.1017/s0022172400070364

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  5 in total

1.  A study of gall-stones and included worms in recurrent pyogenic cholangitis.

Authors:  T B TEOH
Journal:  J Pathol Bacteriol       Date:  1963-07

2.  A study of Escherichia coli isolated from chronic urinary infection.

Authors:  K A Bettelheim; J Taylor
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

3.  Correlation between uropathogenic properties of Escherichia coli from urinary tract infections and the antibody-coated bacteria test and comparison with faecal strains.

Authors:  H J Brooks; B A Benseman; J Peck; K A Bettelheim
Journal:  J Hyg (Lond)       Date:  1981-08

4.  Serotypes of Escherichia coli from urinary tract infections in Hong Kong.

Authors:  W T Wong; K A Bettelheim
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-12

5.  The bacteriology of recurrent pyogenic cholangitis and associated diseases.

Authors:  W T Wong; C H Teoh-Chan; C T Huang; F C Cheng; G B Ong
Journal:  J Hyg (Lond)       Date:  1981-12
  5 in total
  2 in total

1.  Bacteria in bile of patients with bile duct inflammation.

Authors:  K Kosowski; E Karczewska; A Kasprowicz; J Andziak; P B Heczko
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

2.  Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota.

Authors:  Janelle S Ayres; Norver J Trinidad; Russell E Vance
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.